(R) -CR8
(R) -CR8 is a potent and selective CDK inhibitor.A delayed systemic post-LFP administration at 3 hours of CR8--a potent second-generation cyclin-dependent kinase (CDK) inhibitor.
Product Specifications
CAS Number
294646-77-8
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
431.53
Molecular Formula
C24H29N7O
Notes
Research use only, not for human use.
Receptor
CDK
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1375122-01 0.02 mg (E-Coli)
Recombinant Human 26S proteasome non-ATPase regulatory subunit 6 (PSMD6)
Ask
View Details 
MBS1375122-02 0.02 mg (Yeast)
Recombinant Human 26S proteasome non-ATPase regulatory subunit 6 (PSMD6)
Ask
View Details MBS1375122-03 0.1 mg (E-Coli)
Recombinant Human 26S proteasome non-ATPase regulatory subunit 6 (PSMD6)
Ask
View Details MBS1375122-04 0.1 mg (Yeast)
Recombinant Human 26S proteasome non-ATPase regulatory subunit 6 (PSMD6)
Ask
View Details 
MBS1375122-05 0.02 mg (Baculovirus)
Recombinant Human 26S proteasome non-ATPase regulatory subunit 6 (PSMD6)
Ask
View Details MBS1375122-06 0.02 mg (Mammalian-Cell)
Recombinant Human 26S proteasome non-ATPase regulatory subunit 6 (PSMD6)
Ask
View Details